The assessment of pathological response to neoadjuvant chemotherapy in muscle- invasive bladder cancer patients with DCE- MRI and DWI: a systematic review and meta-analysis

被引:1
|
作者
Zong, Ruilong [1 ]
Ma, Xijuan [1 ]
Shi, Yibing [1 ]
Geng, Li [2 ]
机构
[1] Xuzhou Cent Hosp, Dept Radiol, Xuzhou 221000, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Radiol, Xuzhou, Peoples R China
来源
BRITISH JOURNAL OF RADIOLOGY | 2023年 / 96卷 / 1150期
关键词
CONTRAST-ENHANCED MRI; URINARY-BLADDER; TUMOR HETEROGENEITY; CELL CARCINOMA; ANGIOGENESIS; DIFFUSIVITY; PREDICTION; CISPLATIN;
D O I
10.1259/bjr.20230239
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: The purpose of this meta-analysis was to determine the value of dynamic contrast-enhanced- MRI (DCE- MRI) and diffusion-weighted imaging (DWI) in evaluating the pathological response of muscle invasive bladder cancer (MIBC) to neoadjuvant chemotherapy (NAC), and further indirectly compare the diagnostic performance of DCE- MRI and DWI. Methods: Literatures associated to DCE- MRI and DWI in the evaluation of pathological response of MIBC to NAC were searched from PubMed, Cochrane Library, web of science, and EMBASE databases. The quality assessment of diagnostic accuracy studies 2 tool was used to assess the quality of studies. Pooled sensitivity (SE), specificity (SP), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and the area under the receiver operating characteristic curves (AUC) with their 95% confidence intervals (CIs) were calculated to evaluate the diagnostic performance of DCE- MRI and DWI in predicting the pathological response to NAC in patients with MIBC. Results: There were 11 studies involved, 6 of which only underwent DCE-MRI examination, 4 of which only underwent DWI examination, and 1 of which underwent both DCE-MRI and DWI examination. The pooled SE, SP, PLR, NLR, DOR of DCE- MRI were 0.88 (95% CI: 0.78- 0.93), 0.88 (95% CI: 0.67-0.96), 7.4 (95% CI: 2.3-24.2), 0.14 (95% CI: 0.07-0.27), and 53 (95% CI: 10-288), respectively. The pooled SE, SP, PLR, NLR, DOR of DWI were 0.83 (95% CI: 0.75-0.88), 0.88 (95% CI: 0.81-0.93), 7.1 (95% CI: 4.3-11.7), 0.20 (95% CI: 0.14-0.28), and 36 (95% CI:18-73), respectively. The AUCs of SROC curve for DCE- MRI and DWI were 0.93 (95% CI: 0.91-0.95) and 0.92 (95% CI: 0.89-0.94), respectively. There were no significant differences between DWI and DCE- MRI for SE, SP, and AUC. Conclusion: This meta-analysis demonstrated high diagnostic performance of both DCE- MRI and DWI in predicting the pathological response to NAC in MIBC. DWI might be a potential substitute for DCE- MRI, with no significant difference in diagnostic performance between the two. However, caution should be taken when applying our results, as our results were based on indirect comparison. Advances in knowledge: No previous studies have comprehensively analysed the value of DCE- MRI and DWI in evaluating the pathological response to NAC in MIBC. According to the current study, both DCE- MRI and DWI yielded high diagnostic performance, with the AUCs of 0.93 and 0.92, respectively. Indirect comparison no significant difference in the diagnostic performan-ceof DCE- MRI and DWI.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis
    Malik, B.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials
    Kim, Hyung Suk
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    Ku, Ja Hyeon
    ONCOTARGET, 2017, 8 (46) : 81204 - 81214
  • [43] Intravesical chemotherapy plus BCG in non-muscle invasive bladder cancer. A systematic review with meta-analysis
    Houghton, B.
    Hayne, D.
    Brown, C.
    Chalasani, V.
    Patel, M.
    Davis, I.
    Stockler, M.
    BJU INTERNATIONAL, 2011, 107 : 11 - 11
  • [44] Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
    Lanpeng Lu
    Chaohu Chen
    Hui Cheng
    Hui Ding
    Junqiang Tian
    Hanzhang Wang
    Zhiping Wang
    BMC Cancer, 23
  • [45] Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
    Lu, Lanpeng
    Chen, Chaohu
    Cheng, Hui
    Ding, Hui
    Tian, Junqiang
    Wang, Hanzhang
    Wang, Zhiping
    BMC CANCER, 2023, 23 (01)
  • [46] PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN A MULTICENTRE COHORT OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER
    Zargar, Homayoun
    Fairey, Adrian S.
    Mertens, Laura
    Espiritu, Patrick N.
    Dinney, Colin P.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Nils E.
    Montgomery, Jeffrey S.
    Gandhi, Nilay
    Griffin, Joshua
    Yu, Evan Y.
    Vasdev, Nikhil
    Campain, Nicholas J.
    Xylinas, Evanguelos
    Horenblas, Simon
    Youssef, David
    Kassouf, Wassim
    Shariat, Shahrokh F.
    Aning, Jonathan J.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    Morgan, Todd M.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Shah, Jay B.
    Spiess, Philippe E.
    van Rhijn, B. W.
    Daneshmand, Siamak
    Black, Peter C.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E558 - E558
  • [47] Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data
    Bono, AV
    Goebell, PJ
    Groshen, S
    Lehmann, J
    Studer, U
    Torti, FM
    Abol-Enein, H
    Bassi, P
    Boyer, M
    Coppin, CML
    Cortesi, E
    Hall, RR
    Horwich, A
    Malmström, PU
    Martínez-Piñeiro, JA
    Sengelov, L
    Sherif, A
    Wallace, DMA
    Clarke, NW
    Roberts, JT
    Sylvester, R
    Parmar, MKB
    Stewart, LA
    Tierney, JF
    Vale, CL
    EUROPEAN UROLOGY, 2005, 48 (02) : 189 - 201
  • [48] Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis
    Di Nisio, M.
    Candeloro, M.
    Rutjes, A. W. S.
    Porreca, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (07) : 1336 - 1346
  • [49] Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: a systematic review and meta-analysis
    He, Jia
    Wang, Shang-xian
    Liu, Peng
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1159): : 1243 - 1254
  • [50] Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta-analysis
    Gaber, Charles E.
    Sarker, Jyotirmoy
    Abdelaziz, Abdullah I.
    Okpara, Ebere
    Lee, Todd A.
    Klempner, Samuel J.
    Nipp, Ryan D.
    CANCER MEDICINE, 2024, 13 (04):